National
LGBT March on Washington participants celebrate King legacy
Those who took part said civil rights leader would have backed gay rights

José Gutierrez, founder of the Latino GLBT History Project, at the National March on Washington (Washington Blade photo by Jon Wooten)
Liz Abzug, daughter of the late-former New York Congresswoman Bella Abzug who introduced the first federal gay rights bill in 1975, was 11-years-old when she and her mother attended the March on Washington in 1963.
She told the Washington Blade on Saturday her mother would have certainly returned to the Lincoln Memorial five decades later.
“She’d be up there speaking in the front,” Liz Abzug said as she stood with members of Congregation Beit Simchat Torah, an LGBT synagogue in New York City, on the National Mall. “She’d be screaming and speaking and charging up and thrilled, but saying we have unfinished business.”
Liz Abzug is among the LGBT rights advocates who joined the tens of thousands of people who commemorated the 1963 march during which Martin Luther King, Jr., delivered his famous “I Have a Dream” speech.
American Federation of Teachers President Randi Weingarten; National Black Justice Coalition Executive Director Sharon Lettman-Hicks, Rev. MacArthur Flournoy of the Human Rights Campaign; Service Employees International Union President Mary Kay Henry and Adrian Shanker, president of Equality Pennsylvania, are among those who joined Rev. Al Sharpton, NAACP President Benjamin Jealous and others at the Lincoln Memorial. New York City Council Speaker Christine Quinn and members of the National Gay and Lesbian Task Force, Equality Maryland, the Gay and Lesbian Community Center of Baltimore, the Latino GLBT History Project and other LGBT groups also took part.
“I’m here with my brothers and sisters, not only in the union movement, but with LGBT people, with African Americans from the civil rights movement,” Suzanne Keller of Richmond, Va., told the Blade as she stood along the reflecting pool in front of the Lincoln Memorial with her girlfriend who was 13-years-old when she watched the 1963 March on Washington on television. “I know I’m here with my people.”
Lance Chen-Hayes of Princeton, N.J., held a sign in support of marriage rights for same-sex couples and affordable health care as he stood on the Mall with his husband, Stuart Chen-Hayes, and their son Kalani. Stuart Chen-Hayes cited a list of people whom he considers heroes that include Bayard Rustin, who organized the 1963 March on Washington, and former U.S. Army private Chelsea Manning whom a military judge on Wednesday sentenced to 35 years in prison for leaking classified documents to Wikileaks.
“If we don’t stand up, speak up and be in the streets, who will,” Stuart Chen-Hayes told the Blade. “It’s especially important for us who are lesbian, gay, transgender and parents because there’s all sorts of folks who fought for us 50 years ago and long before that. It’s just continuing the struggle for civil rights and human rights.”
Anders Minter, a gay man who is a member of the United Auto Workers, traveled to the nation’s capital from Amherst, Mass. to attend the march.
He told the Blade he felt “incredible power and solidarity” while marching, but noted what he described as a “great tension.”
“It’s been 50 years since we’ve come together as a country with a focus on economic justice and social justice,” Minter said, noting the commemoration of the 1963 March on Washington took place against the backdrop of June’s U.S. Supreme Court decision that struck down a crucial portion of the Voting Rights Act and last month’s acquittal of George Zimmerman in the 2012 shooting death of Florida teenager Trayvon Martin. “It’s been a long journey, but there’s a long journey ahead.”
D.C. officials used the march to highlight the issue of statehood for the nation’s capital.
D.C. Mayor Vincent Gray noted during a pro-statehood rally at the D.C. War Memorial near the Mall that people of “different sexual orientations and genders” were among those who attended the 1963 March on Washington.
“We’re demanding justice because justice is exactly what we are here to accomplish,” he said.
D.C. Council Chair Phil Mendelson (D-At-Large,) D.C. Council members Jack Evans (D-Ward 2,) Muriel Bowser (D-Ward 4,) Marion Barry (D-Ward 8,) Vincent Orange (D-At-Large,) Anita Bonds (D-At-Large) and David Grosso (I-At-Large) and D.C. Police Chief Cathy Lanier are among those who also attended the pro-statehood rally.
Roland Martin, a former CNN commentator whom the network suspended in 2012 over homophobic tweets he sent during that year’s Super Bowl, also spoke.

D.C. Congressional Del. Eleanor Holmes Norton speaks at a pro-D.C. statehood rally at the D.C. War Memorial on Aug. 24, 2013. (Washington Blade photo by Michael K. Lavers)
“This morning we serve notice as the March on Washington 2013 begins that we, who have fewer rights than almost any who will march today, can no longer allow the deliberate disempowerment and denial of our rights to go unnoticed, unnoted, unmentioned and ignored,” D.C. Congressional Del. Eleanor Holmes Norton, who helped to organize the 1963 March on Washington, said. “No more marches and ignoring D.C.”
King understood rights are ‘not divisible’
Many of the march participants with whom the Blade spoke said they feel King would have supported LGBT rights if he were still alive.
“His message of equality, his message of inclusion of all people was loud and clear in everything that he wrote and every speech that he gave,” Grosso said.
“We’re humans and everybody deserves the same rights,” Daniel Trejo of Columbia Heights told the Blade as he prepared to march to the Lincoln Memorial with the D.C. Office on Latino Affairs.
Minter referenced King’s “I Have a Dream” speech as he discussed how he feels the slain civil rights leader would have backed LGBT rights.
“Martin Luther King was an incredible listener, as much as he was an incredible orator,” Minter said. “Part of acceptance and love is listening and understanding and I think he would have added this to his work.”
Both Liz Abzug and Keller noted to the Blade the slain civil rights leader’s widow, Coretta Scott King, backed marriage rights for same-sex couples before she passed away in 2006.
“Dr. King had a key understanding that rights are not divisible,” Keller said. “If we don’t have human rights for everybody, we don’t have human rights for anybody.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:

